OR WAIT null SECS
Nathan Jessop is a columnist for Pharmaceutical Technology Europe.
November 30, 2010
A European-wide awareness initiative hopes to tackle the issue of antibiotic over-prescription, but industry must also be encouraged to make further investments.
October 31, 2010
There has been increasing cooperation between the EMA and the FDA in recent years, and this looks set to continue in the future.
October 01, 2010
The early part of the decade saw a decline in vaccine sales and manufacture, but finally the industry is bouncing back, with Europe particularly well placed to make an impact.
September 01, 2010
Despite the poor economic climate, large-scale mergers and acquisitions in the pharmaceutical industry struck back with a vengeance in 2009.